ArticleBlood2018

Pro B, Advani R, Brice P, et al. Five-year results of brentuximab vedotin in patients with relapsed or refractory systemic anaplastic large cell lymphoma.

PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.